SMTL ID : 3be2.1

Crystal structure of the VEGFR2 kinase domain in complex with a benzamide inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.75 Å

Oligo State

monomer

Ligands

1 x RAJ: N-{3-[3-(DIMETHYLAMINO)PROPYL]-5-(TRIFLUOROMETHYL)PHENYL}-4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]BENZAMIDE(Non-covalent)

RAJ.1: 20 residues within 4Å: Chain A: L.26, V.34, A.52, K.54, E.71, L.75, V.84, V.85, T.102, E.103, F.104, C.105, L.155, H.162, L.171, I.180, C.181, D.182, F.183, G.184 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.26, A:A.52, A:K.54, A:L.75, A:T.102, A:L.171, A:D.182 Hydrogen bonds: A:E.71, A:T.102, A:C.105, A:D.182 Salt bridges: A:E.71, A:D.182 Halogen bonds: A:I.180

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Harmange, J.C. et al., Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation. J.Med.Chem. (2008)

Release Date

2008-04-08

Peptides

Vascular endothelial growth factor receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Vascular endothelial growth factor receptor 2

Related Entries With Identical Sequence